Form 4 for ABT Abbott Laboratories
Accepted 2023-01-03 00:00:00 ET · period of report 2022-12-29 · accession 0001415889-23-000127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-03 | 2022-12-29 | ABT | Karam Sammy | SVP | S - Sale | $108.75 | -4,200 | 26.5K | -14% | -$456.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2022-12-29 | S | D | 4,200 | $108.75 | 26,462 | D | — | — |